Adjuvant treatment of early-stage breast cancer with eribulin mesylate following dose-dense doxorubicin and cyclophosphamide: Preliminary results from a phase 2, single-arm feasibility study Meeting Abstract


Authors: Traina, T. A.; Hudis, C.; Fornier, M.; Lake, D.; Lehman, R.; Berkowitz, A. P.; Rege, J.; Liao, J.; Cox, D.; Seidman, A. D.
Abstract Title: Adjuvant treatment of early-stage breast cancer with eribulin mesylate following dose-dense doxorubicin and cyclophosphamide: Preliminary results from a phase 2, single-arm feasibility study
Meeting Title: 35th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS)
Journal Title: Cancer Research
Volume: 72
Issue: 24 Suppl.
Meeting Dates: 2012 Dec 4-8
Meeting Location: San Antonio, TX
ISSN: 0008-5472
Publisher: American Association for Cancer Research  
Date Published: 2012-12-01
Language: English
ACCESSION: WOS:000209704902156
DOI: 10.1158/0008-5472.sabcs12-p1-13-11
PROVIDER: wos
Notes: Meeting Abstract: P1-13-11 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Andrew D Seidman
    318 Seidman
  2. Clifford Hudis
    905 Hudis
  3. Diana E Lake
    89 Lake
  4. Monica Nancy Fornier
    158 Fornier
  5. Tiffany A Traina
    250 Traina
  6. Robert James Lehman
    10 Lehman